Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: Results from the ATHENA HPV study

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 3, 2013, Pages 184.e1-184.e11

  Cox, J Thomas ^e   Castle, Phillip E ^a   Behrens, Catherine M ^b   Sharma, Abha ^b   Wright Jr , Thomas C ^c   Cuzick, Jack ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b ROCHE MOLECULAR SYSTEMS   (United States)

^c NewYork Presbyterian Hospital   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^e NONE

Author keywords

Addressing the Need for Advanced HPV Diagnostics; atypical squamous cells of undetermined significance; cotesting; human papillomavirus; human papillomavirus 16 18; low grade squamous intraepithelial lesion

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER SCREENING; COLPOSCOPY; CYTODIAGNOSIS; EMERGENCY HEALTH SERVICE; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS TYPING;

EID: 84874768149     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2012.11.020     Document Type: Article

References (23)

1. V.A. Moyer US Preventive Services Task Force Screening for cervical cancer: US Preventive Services Task Force Recommendation Statement Ann Intern Med 156 2012 880 891 W312.
2. D. Saslow, D. Solomon, H.W. Lawson American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer Am J Clin Pathol 137 2012 516 542
3. American College of Obstetrics and Gynecology Cervical cancer recommendations http://www.acog.org/About-ACOG/Announcements/New-Cervical- Cancer-Screening-recommendations Accessed June 1, 2012
4. M.H. Stoler, T.C. Wright Jr, A. Sharma High-risk human papillomavirus testing in women with ASC-US cytology: results from the ATHENA HPV study Am J Clin Pathol 135 2011 468 475
5. P.E. Castle, M.H. Stoler, T.C. Wright Jr, A. Sharma, T.L. Wright, C.M. Behrens Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Lancet Oncol 12 2011 880 889
6. T.C. Wright Jr, M.H. Stoler, C.M. Behrens, R. Apple, T. Derion, T.L. Wright The ATHENA human papillomavirus study: design, methods, and baseline results Am J Obstet Gynecol 206 2012 46.e1 46.e11
7. T.C. Wright Jr, M.H. Stoler, A. Sharma Evaluation of HPV-16 and HPV-18 genotyping for the triage of women with high-risk HPV+ cytology-negative results Am J Clin Pathol 136 2011 578 586
8. M.R. McCredie, K.J. Sharples, C. Paul Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study Lancet Oncol 9 2008 425 434
9. J.J. Kim, T.C. Wright, S.J. Goldie Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance JAMA 287 2002 2382 2390
10. J.J. Kim, T.C. Wright, S.J. Goldie Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy J Natl Cancer Inst 97 2005 888 895
11. S.L. Kulasingam, J.J. Kim, W.F. Lawrence Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion Triage Study (ALTS) J Natl Cancer Inst 98 2006 92 100
12. M. Arbyn, P. Sasieni, C.J. Meijer, C. Clavel, G. Koliopoulos, J. Dillner Chapter 9: clinical applications of HPV testing: a summary of meta-analyses Vaccine 24 Suppl 3 2006 S3/78, S3/89
13. W. Kinney, B. Fetterman, J.T. Cox, T. Lorey, T. Flanagan, P.E. Castle Characteristics of 44 cervical cancers diagnosed following Pap-negative, high risk HPV-positive screening in routine clinical practice Gynecol Oncol 121 2011 309 313
14. D.C. Rijkaart, J. Berkhof, F.J. van Kemenade HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications Br J Cancer 106 2012 975 981
15. A.C. Rodriguez, M. Schiffman, R. Herrero Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections J Natl Cancer Inst 100 2008 513 517
16. J. Cuzick, A. Szarewski, D. Mesher Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study Int J Cancer 122 2008 2294 2300
17. M. Leinonen, P. Nieminen, L. Kotaniemi-Talonen Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting J Natl Cancer Inst 101 2009 1612 1623
18. P. Naucler, W. Ryd, S. Tornberg Efficacy of HPV DNA testing with cytology triage and/or repeat HPV DNA testing in primary cervical cancer screening J Natl Cancer Inst 101 2009 88 99
19. D.C. Rijkaart, J. Berkhof, L. Rozendaal Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial Lancet Oncol 13 2012 78 88
20. G. Ronco, P. Giorgi-Rossi, F. Carozzi Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol 11 2010 249 257
21. R. Sankaranarayanan, B.M. Nene, S.S. Shastri HPV screening for cervical cancer in rural India N Engl J Med 360 2009 1385 1394
22. S. de Sanjose, W.G. Quint, L. Alemany Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol 11 2010 1048 1056
23. H.C. Kitchener, M. Almonte, C. Thomson HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial Lancet Oncol 10 2009 672 678